课题基金 / 基金详情

The eosinophil: Anti-parasite effector cell or mediator of pathology?

The eosinophil: Anti-parasite effector cell or mediator of pathology?
嗜酸性粒细胞:抗寄生虫效应细胞还是病理介质?
批准号:
BB/D013550/1
负责人:
Rachel Lawrence
金额:
$38.33万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2006
资助国家:
英国
项目状态:
已结题
起止时间:
2006 至 --

项目摘要

项目成果

Rachel Lawrence的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Parasites can live relatively quietly in their hosts or they can cause excessive tissue damage which seriously affects the life of the infected individual. This project will study a particular cell type, the eosinophil, which appears to be capable of either curing the individual of disease or of causing harmful tissue reactions. Millions of people and animals in the world are infected by parasitic nematode worms. These parasites occupy a multitude of different sites within the body, from the gut to the skin or blood. The damage that worms cause varies between different parasite species and also between different infected individuals. Some individuals are relatively resistant to infection with worms, while others, are particularly susceptible. Resistance to parasitic nematode disease depends on the immune responses that the body develops to fight these infections. Interestingly, in many infections, although a specific type of immune response can kill parasitic worms, that particular immune response may also be guilty of damaging the tissues of the host organism. Therefore in areas of the world where individuals are continually at risk of infection with parasitic worms, the immune response can be viewed as a finely/balanced see-saw that rocks between the ability to kill parasites and the ability of the response to cause harm. As researchers, we wish to find out the triggers that push the see-saw in one direction or the other and the controls that the body puts in place to prevent the balance from being biased too strongly in one or other direction. We have identified a particular cell-type, the eosinophil, that appears to be important in parasite-killing but when over-active it is also involved in tissue damage. Our aim in this research is to definitively establish, once and for all, that this cell type, the eosinophil, is capable of killing parasites and of damaging tissues. We will then establish the biological factors that are produced by eosinophils in both of these situations to try and define whether there are differences between esoinophils that kill parasites and those that cause damage. Lastly we will try to identify particular immune responses that limit the damage caused by eosinophils. This work is particularly exciting because it is only recently that scientists have developed the technological tools that will help us to identify the role played by eosinophils. In addition, immune responses to parasitic worms are remarkably similar to the immune responses that cause asthma, therefore the results of our studies will be useful both for fighting infections with worms and for fighting the symptoms of asthma.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1371/journal.pbio.1000525
发表时间: 2010-10-19
期刊: PLoS biology
影响因子: 9.8
作者: [Babayan SA, Read AF, Lawrence RA, Bain O, Allen JE]
通讯作者: Allen JE
DOI: 10.1016/j.immuni.2016.03.003
发表时间: 2016-04-19
期刊: Immunity
影响因子: 32.4
作者: [Matthews SP, McMillan SJ, Colbert JD, Lawrence RA, Watts C]
通讯作者: Watts C
DOI: 10.1371/journal.ppat.1003988
发表时间: 2014-03
期刊: PLoS pathogens
影响因子: 6.7
作者: [Cadman ET, Thysse KA, Bearder S, Cheung AY, Johnston AC, Lee JJ, Lawrence RA]
通讯作者: Lawrence RA
DOI: 10.1111/imcb.12219
发表时间: 2019-03-01
期刊: IMMUNOLOGY AND CELL BIOLOGY
影响因子: 4
作者: [Ahmed,Rubina, Cadman,Emma T., Lawrence,Rachel A.]
通讯作者: Lawrence,Rachel A.
A state-of-the-art flow cytometer for a multi-disciplinary integrative biology department
  • 批准号:
    BB/F011180/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $18.62万
  • 财政年份:
    2008
  • 负责人:
    Rachel Lawrence
  • 依托单位:
国内基金
海外基金
基于spA-Gel负载Anti-HMGB1原位靶向免疫耐受的猪胰岛类器官移植研
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    程瑶
  • 依托单位:
TKIs氘代化修饰通过促进HCC铁死亡增强免疫原性并增敏anti-PD-1治疗的机制研究
  • 批准号:
    JCZRQN202500319
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
肺癌外周血淋巴细胞亚群预测anti-PD1/PDL1疗效的鉴定及应用研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    仇凤启
  • 依托单位:
Anti-MDA5阳性皮肌炎病人的NK细胞数量与功能改变在间质性肺疾病中的作用与机制研究
  • 批准号:
    MS25H100014
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    韩咏梅
  • 依托单位: